回复乔·奥沙利文、丹尼尔·海因里希、尼古拉斯·D·詹姆斯等人致编辑的信：关于反对欧洲药品管理局更改镭-223用于治疗转移性去势抵抗性前列腺癌的药品标签的案例。《欧洲泌尿外科杂志》2019年；75:e53 - Suppr

Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al's Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e53.

作者信息

Leibowitz-Amit Raya

机构信息

Oncology Institute, Sheba Medical Center, Tel Hashmoer, Israel; Faculty of medicine, Tel-Aviv university, Tel-Aviv, 69978 ,Israel.

出版信息

Eur Urol. 2019 Jul;76(1):e19. doi: 10.1016/j.eururo.2019.03.013. Epub 2019 Mar 28.

DOI:10.1016/j.eururo.2019.03.013

PMID:30928161

Abstract

摘要

相似文献

Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al's Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e53.回复乔·奥沙利文、丹尼尔·海因里希、尼古拉斯·D·詹姆斯等人致编辑的信：关于反对欧洲药品管理局更改镭-223用于治疗转移性去势抵抗性前列腺癌的药品标签的案例。《欧洲泌尿外科杂志》2019年；75:e53

Eur Urol. 2019 Jul;76(1):e19. doi: 10.1016/j.eururo.2019.03.013. Epub 2019 Mar 28.

Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al.'s Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e51-2.对乔·奥沙利文、丹尼尔·海因里希、尼古拉斯·D·詹姆斯等人致编辑的信的回复，信的主题为：反对欧洲药品管理局更改镭-223用于治疗转移性去势抵抗性前列腺癌的药品标签。《欧洲泌尿外科杂志》2019年；第75卷：e51 - 2。

Eur Urol. 2019 Mar;75(3):e53. doi: 10.1016/j.eururo.2018.11.053. Epub 2019 Jan 15.

Re: Kenneth A. Iczkowski's Letter to the Editor re: Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73-5.回复：肯尼斯·A·伊茨科夫斯基致编辑的信，主题为：回复：鲁道夫·蒙蒂罗尼、西尔维娅·加斯帕里尼、罗伯塔·马祖切利等人致编辑的信，主题为：卡里姆·A·图杰尔、詹姆斯·A·伊斯特姆。前哨淋巴结概念及前列腺癌淋巴结转移检测的新方法。《欧洲泌尿外科杂志》2016年；70卷：738 - 9页：在虚拟全层组织学切片中观察到的前列腺和精囊周围脂肪组织中的前哨淋巴结。《欧洲泌尿外科杂志》2017年；71卷：e73 - 5页。

Eur Urol. 2017 Aug;72(2):e37-e38. doi: 10.1016/j.eururo.2017.02.032. Epub 2017 Mar 11.

Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73-5.回复：鲁道夫·蒙蒂罗尼、西尔维娅·加斯帕里尼、罗伯塔·马祖切利等人致编辑的信，主题为：卡里姆·A·图耶尔、詹姆斯·A·伊斯顿。前哨淋巴结概念及检测前列腺癌淋巴结转移的新方法。《欧洲泌尿外科杂志》2016年；70卷：738 - 9页：在虚拟全层组织学切片中观察到的前列腺和精囊周围脂肪组织中的前哨淋巴结。《欧洲泌尿外科杂志》2017年；71卷：e73 - 5页。

Eur Urol. 2017 Aug;72(2):e36. doi: 10.1016/j.eururo.2017.02.033. Epub 2017 Mar 9.

Reply to Piet R. Dirix, Carole Mercier, and Luc Y. Dirix's Letter to the Editor re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548-51.对皮耶特·R·迪里克斯、卡罗尔·梅西埃和吕克·Y·迪里克斯致编辑的信的回复，信的主题为：法比安·洛豪斯、克劳斯·措费尔、斯特芬·勒克等人。局部消融放疗能否将去势抵抗性前列腺癌逆转至疾病的早期阶段？《欧洲泌尿外科杂志》2019年；75卷：548 - 551页。

Eur Urol. 2019 Oct;76(4):e103-e104. doi: 10.1016/j.eururo.2019.06.021. Epub 2019 Jun 27.

Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives.镭-223 治疗骨转移去势抵抗性前列腺癌患者的选择：新建议和未来展望。

Clin Genitourin Cancer. 2019 Apr;17(2):79-87. doi: 10.1016/j.clgc.2018.11.008. Epub 2018 Nov 22.

Reply to Alessia Cimadamore, Marina Scarpelli, Liang Cheng, et al's Letter to the Editor, re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019, 76:871.回复阿莱西娅·奇马达莫尔、玛丽娜·斯卡尔佩利、梁成等人致编辑的信，关于：玛丽亚·基娅拉·西吉诺尔菲、贝尔纳多·罗科对《欧洲泌尿外科学会（EAU）指南：2019年前列腺癌》的明智之言。莫泰特N、范登伯格RCN、布里斯E等人。https://uroweb.org/guideline/prostate-Cancer/。《欧洲泌尿外科杂志》2019年，76:871。

Eur Urol. 2020 May;77(5):e128-e129. doi: 10.1016/j.eururo.2020.02.006. Epub 2020 Feb 14.

The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer.反对欧洲药品管理局更改用于治疗转移性去势抵抗性前列腺癌的镭-223标签的理由。

Eur Urol. 2019 Mar;75(3):e51-e52. doi: 10.1016/j.eururo.2018.11.003. Epub 2018 Nov 16.

Reply to Salma Kaochar, Nicholas Mitsiades' Letter to the Editor re: Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al. Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. Eur Urol 2020, 78:652-6. Can Mutant SPOP Become an Actionable Biomarker for Precision Oncology Management of Prostate Cancer?: SPOP as a Potential Treatment Selection Marker in Prostate Cancer.

Eur Urol. 2021 Mar;79(3):e94-e95. doi: 10.1016/j.eururo.2020.12.009. Epub 2021 Jan 6.

Reply to Ethan B. Ludmir, Zachary R. McCaw, and Lee-Jen Wei's Letter to the Editor re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032. Interpreting the Effect of Ipilimumab following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer.对伊桑·B·卢德米尔、扎卡里·R·麦考和李-珍·魏致编辑信的回复：关于卡里姆·菲扎齐、查尔斯·G·德雷克、托马什·M·比尔等人的研究。多西他赛后转移性去势抵抗性前列腺癌放疗后伊匹木单抗与安慰剂对比的III期试验最终分析确定了长期存活者过多。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.07.032。解读放疗后伊匹木单抗对多西他赛后转移性去势抵抗性前列腺癌患者的疗效。

Eur Urol. 2021 Jan;79(1):e12-e13. doi: 10.1016/j.eururo.2020.10.012. Epub 2020 Oct 26.

引用本文的文献

A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population.一项前瞻性观察性登记研究，评估镭-223 治疗非研究人群的临床结局。

Int J Cancer. 2020 Aug 15;147(4):1143-1151. doi: 10.1002/ijc.32851. Epub 2020 Jan 21.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al's Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e53.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献